Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Dermatitis herpetiformis
ADR ID BADD_A07149
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.02      Skin autoimmune disorders NEC
10.04.02.014      Dermatitis herpetiformis
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.01      Bullous conditions
23.03.01.029      Dermatitis herpetiformis
Description Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis. [MeSH]
MedDRA Code 10012468
MeSH ID D003874
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Dermatitis herpetiformis | Juvenile dermatitis herpetiformis | Dermatitis Herpetiformis | Duhring's Disease | Disease, Duhring's | Duhrings Disease | Duhring Disease | Disease, Duhring
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000148%
BADD_D02236Tofacitinib0.000241%
The 1th Page    1    Total 1 Pages